A masters program in Artificial Intelligence and Big Data. My field of interest is in the application of AI in the area of pharmaceutical industry: medical image diagnosis, disease diagnosis, drug discovery, drug candidate pipeline management, human resourcing, company NLP sentiment analysis, object detection of medical diseases. My research thesis focused on Generative Adversarial Network (GAN) to synthesize clinical research data of trial subjects in drug development.

eMBA program

1. Manage clinical study/studies according to local and global regulatory requirements and company SOPs, and supporting clinical strategy defined in Clinical Study Plan.2. Lead cross functional Study Execution Team, including Takeda functions, Strategic Partners and other vendors to ensure study goals are met, on time and within budget. Includes leading and organizing cross functional study team meetings.3. Drafting and coordinating the finalization of protocol development.4. Management of Strategic Partners, including setting expectations, training, CRO Oversight process, Task Orders, Change Orders, invoice approval and financial reconciliation process for assigned study. Responsible as Takeda first point of contact for Issue Management process for assigned study. 5. Leads the evaluation and selection of required vendors, including contract and budget negotiation, invoice approval and financial reconciliation process. Responsible for day-to-day management of vendors working on assigned study, including setting expectations, training, managing timelines and deliverables, and issue management. Provides Clinical Operations input to other important study activities, including but not limited to: site identification and selection, enrollment models, clinical supply planning and drug supply, organization of investigator and vendor meetings, development of informed consents forms, planning and management of Trial Master File, development of monitoring plans, development of IxRS systems, development of EDC / Case Report Forms, review of data during the study, data cleaning and database lock, writing the Clinical Study Report.

The Global Regulatory Lead of Study Start-Up oversees and supervise the Start-Up Teams in multiple regions to obtain Regulatory and Ethics approvals and to lead all Start-Up activities prior to clinical study initiation.Studies (Phase/Indication):Phase III Adjuvant Treatment for Renal Cell CarcinomaPhase III Open Label Treatment for Non Small Cell Lung CancerPhase III Treatment for Relapsing Multiple Sclerosis

The Regulatory Lead of Study Start-Up oversees and supervise the Start-Up Teams in Asia-Pac regions to obtain Regulatory and Ethics approvals and to lead all Start-Up activities prior to clinical study initiation.Studies (Phase/Indication):Phase III IOP Lowering Therapy in Open Angle Glaucoma

Provide line management support and training to Taiwan's Regulatory Start-Up Specialists.

- EC/RA Submissions and obtainment of approvals- Local Import/Export permit applications- Site Contract/Budget Negotiation- Essential Document Site IP Pack collection and review - Facilitate IP Shipment to Site - Handover from Start-Up to CRAsStudies (Phase/Indication):Phase III Atrial FibrillationPhase III Deep Vein Thrombosis

Site Selection VisitSite Monitoring Visit

- Vaccine stability testing for novel formulations- Drafting of SOP for photostability testing

- High Throughput Drug Screening for potential neural drug candidates